DNA Synthesis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research, a prominent market research firm, has recently released an in-depth report on the global DNA Synthesis Market. This comprehensive analysis provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report offers a detailed overview of the DNA synthesis industry, featuring exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global DNA synthesis market is forecast to expand at a CAGR of 14.5% and thereby increase from a value of US$3.3 Bn in 2023, to US$ 8.5 Bn by the end of 2030.

Key Insights:

DNA Synthesis Market Size (2023): US$3.3 Bn
Projected Market Value (2030): US$8.5 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 14.5%
Historical Market Growth Rate (CAGR 2018 to 2022): 6.0%

DNA Synthesis Market - Report Scope:

The DNA Synthesis Market is positioned for significant growth, driven by advancements in genetic research, the growing demand for synthetic biology applications, and the development of personalized medicine. This market serves research institutions, pharmaceutical companies, biotechnology firms, and academic laboratories, offering DNA synthesis services and products for various applications. Market growth is fueled by the increasing focus on precision medicine, synthetic biology research, and the need for custom DNA sequences in genetic engineering.

Market Growth Drivers:

The global DNA Synthesis Market benefits from several key growth drivers. The expansion of genetic research, the rise of synthetic biology as a transformative field, and the increasing adoption of DNA synthesis in various applications contribute to market expansion. DNA synthesis plays a crucial role in gene editing, drug discovery, and the development of novel therapies. Moreover, the demand for custom DNA sequences, gene synthesis services, and synthetic genes for research purposes drive market adoption. The market is also influenced by the accelerating pace of genomics research and the integration of DNA synthesis in next-generation sequencing technologies.

Market Restraints:

Despite promising growth prospects, the DNA Synthesis Market faces challenges related to cost constraints, ethical considerations, and competition from alternative technologies. The cost of DNA synthesis services and products may impact the affordability for smaller research institutions and laboratories. Ethical concerns related to the synthesis of potentially harmful genetic material pose challenges for certain applications. Additionally, competition from alternative gene editing and synthesis technologies, such as CRISPR/Cas9, may affect the market share of traditional DNA synthesis methods.

Market Opportunities:

The DNA Synthesis Market presents significant growth opportunities driven by ongoing research, technological innovations, and the expansion of applications in healthcare and biotechnology. The development of high-throughput DNA synthesis platforms, automation technologies, and novel synthesis methods enhances the efficiency and scalability of DNA synthesis services. Furthermore, strategic collaborations, partnerships with pharmaceutical companies, and the introduction of user-friendly, cost-effective DNA synthesis solutions open new avenues for market players to capitalize on emerging opportunities and maintain a competitive edge.

Key Questions Answered in the Report:

What is the Forecast CAGR of the DNA Synthesis Market?
What was the Global Market Size in the Year 2023?
Which Country Held the Largest Market Share in 2023?
Who are the Key Players in the DNAs Synthesis Market?
Which is the Fastest-growing Market Segment by End User?

Competitive Intelligence and Business Strategy:

Leading players in the global DNA Synthesis Market focus on innovation, research and development, and strategic collaborations to gain a competitive edge. These companies invest in the development of advanced DNA synthesis technologies, explore novel synthesis methods, and enhance the scalability and accuracy of their services. Collaborations with pharmaceutical companies, research institutions, and biotechnology firms facilitate market access and improve the adoption of DNA synthesis. Moreover, emphasis on marketing campaigns, education initiatives, and partnerships with industry associations fosters market growth and advances the use of DNA synthesis in the rapidly evolving landscape of genetic research and personalized medicine.

Key Companies Profiled:

Brooks Automation, Inc. (GENEWIZ)
Boster Biological Technology
ProteoGenix
Biomatik
ProMab Biotechnologies, Inc
Thermo Fisher Scientific, Inc
Integrated DNA Technologies, Inc
OriGene Technologies, Inc

DNA Synthesis Market Research Segmentation:

The DNA synthesis industry is witnessing a substantial market share dominated by custom oligonucleotides, especially in the gene library division experiencing rapid growth. The gene libraries, crucial for functional genomics and drug discovery, are driving the overall expansion of DNA synthesis, propelled by the increasing focus on understanding genetic interactions and finding new therapeutic targets.

In terms of sales-focused applications, the Research and Development (R&D) sector takes the lead, deeply integrated into genetics and molecular biology. The pharmaceutical sector within R&D is expected to experience the most rapid expansion due to the rising prominence of personalized medicine and gene therapy, driving the demand for DNA synthesis in therapeutics.

Among end users, biopharmaceutical companies are set to benefit the most from revenue generation in the DNA synthesis market. These companies extensively utilize DNA synthesis for drug discovery, development, and biological production. Additionally, Contract Research Organizations (CROs) are poised for rapid growth as they cater to the outsourcing needs of the biopharmaceutical industry, providing specialized and cost-effective DNA synthesis solutions.

North America dominates the global DNA synthesis market, driven by significant investments from biopharmaceutical companies and research institutions. The region's established biotechnology and pharmaceutical industry, coupled with advanced research facilities and infrastructure, solidify its leadership position. South Asia and the Pacific show the most rapid expansion, fueled by the growing biotech industries in countries like Australia, Singapore, and India. Increasing emphasis on personalized healthcare and genomics, coupled with government initiatives, positions the region as a key player in the evolving DNA synthesis industry.

By Service Type:

Oligonucleotide
Universal Oligonucleotide
Custom Oligonucleotide
Gene
Custom Gene
Gene Library

By Application:

Research and Development
Academic Applications
Industrial Applications
Diagnosis
Therapeutics

By End User:

Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33942

1. Executive Summary

1.1. Global DNA Synthesis Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Service Type Lifecycle Analysis
2.4. DNA Synthesis Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global DNA Synthesis Market Outlook: Service Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Service Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
  - 3.3.3.1. Oligonucleotide
  - 3.3.3.2. Universal Oligonucleotide
  - 3.3.3.3. Custom Oligonucleotide
  - 3.3.3.4. Gene
  - 3.3.3.5. Custom Gene
  - 3.3.3.6. Gene Library
3.4. Market Attractiveness Analysis: Service Type
3.5. Global DNA Synthesis Market Outlook: Application
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.5.3.1. Research and Development
  - 3.5.3.2. Academic Applications
  - 3.5.3.3. Industrial Applications
  - 3.5.3.4. Diagnosis
  - 3.5.3.5. Therapeutics
3.6. Market Attractiveness Analysis: Application
3.7. Global DNA Synthesis Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Biopharmaceutical Companies
  - 3.7.3.2. Academic and Research Institutes
  - 3.7.3.3. Contract Research Organizations
3.8. Market Attractiveness Analysis: End User

4. Global DNA Synthesis Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Service Type
- 5.3.3. By Application
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 5.5.1. Oligonucleotide
- 5.5.2. Universal Oligonucleotide
- 5.5.3. Custom Oligonucleotide
- 5.5.4. Gene
- 5.5.5. Custom Gene
- 5.5.6. Gene Library
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.6.1. Research and Development
- 5.6.2. Academic Applications
- 5.6.3. Industrial Applications
- 5.6.4. Diagnosis
- 5.6.5. Therapeutics
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Biopharmaceutical Companies
- 5.7.2. Academic and Research Institutes
- 5.7.3. Contract Research Organizations
5.8. Market Attractiveness Analysis

6. Europe DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Service Type
- 6.3.3. By Application
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 6.5.1. Oligonucleotide
- 6.5.2. Universal Oligonucleotide
- 6.5.3. Custom Oligonucleotide
- 6.5.4. Gene
- 6.5.5. Custom Gene
- 6.5.6. Gene Library
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.6.1. Research and Development
- 6.6.2. Academic Applications
- 6.6.3. Industrial Applications
- 6.6.4. Diagnosis
- 6.6.5. Therapeutics
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Biopharmaceutical Companies
- 6.7.2. Academic and Research Institutes
- 6.7.3. Contract Research Organizations
6.8. Market Attractiveness Analysis

7. East Asia DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Service Type
- 7.3.3. By Application
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 7.5.1. Oligonucleotide
- 7.5.2. Universal Oligonucleotide
- 7.5.3. Custom Oligonucleotide
- 7.5.4. Gene
- 7.5.5. Custom Gene
- 7.5.6. Gene Library
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.6.1. Research and Development
- 7.6.2. Academic Applications
- 7.6.3. Industrial Applications
- 7.6.4. Diagnosis
- 7.6.5. Therapeutics
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Biopharmaceutical Companies
- 7.7.2. Academic and Research Institutes
- 7.7.3. Contract Research Organizations
7.8. Market Attractiveness Analysis

8. South Asia & Oceania DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Service Type
- 8.3.3. By Application
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 8.5.1. Oligonucleotide
- 8.5.2. Universal Oligonucleotide
- 8.5.3. Custom Oligonucleotide
- 8.5.4. Gene
- 8.5.5. Custom Gene
- 8.5.6. Gene Library
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.6.1. Research and Development
- 8.6.2. Academic Applications
- 8.6.3. Industrial Applications
- 8.6.4. Diagnosis
- 8.6.5. Therapeutics
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Biopharmaceutical Companies
- 8.7.2. Academic and Research Institutes
- 8.7.3. Contract Research Organizations
8.8. Market Attractiveness Analysis

9. Latin America DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Service Type
- 9.3.3. By Application
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 9.5.1. Oligonucleotide
- 9.5.2. Universal Oligonucleotide
- 9.5.3. Custom Oligonucleotide
- 9.5.4. Gene
- 9.5.5. Custom Gene
- 9.5.6. Gene Library
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.6.1. Research and Development
- 9.6.2. Academic Applications
- 9.6.3. Industrial Applications
- 9.6.4. Diagnosis
- 9.6.5. Therapeutics
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Biopharmaceutical Companies
- 9.7.2. Academic and Research Institutes
- 9.7.3. Contract Research Organizations
9.8. Market Attractiveness Analysis

10. Middle East & Africa DNA Synthesis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Service Type
- 10.3.3. By Application
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2023 - 2030
- 10.5.1. Oligonucleotide
- 10.5.2. Universal Oligonucleotide
- 10.5.3. Custom Oligonucleotide
- 10.5.4. Gene
- 10.5.5. Custom Gene
- 10.5.6. Gene Library
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.6.1. Research and Development
- 10.6.2. Academic Applications
- 10.6.3. Industrial Applications
- 10.6.4. Diagnosis
- 10.6.5. Therapeutics
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Biopharmaceutical Companies
- 10.7.2. Academic and Research Institutes
- 10.7.3. Contract Research Organizations
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Service Type Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Brooks Automation, Inc. (GENEWIZ)
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Service Type
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Boster Biological Technology
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Service Type
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. ProteoGenix
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Service Type
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Biomatik
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Service Type
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. ProMab Biotechnologies, Inc
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Service Type
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Thermo Fisher Scientific, Inc
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Service Type
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Integrated DNA Technologies, Inc
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Service Type
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. OriGene Technologies, Inc
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Service Type
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations